Literature DB >> 23595422

Hippocampal demyelination and memory dysfunction are associated with increased levels of the neuronal microRNA miR-124 and reduced AMPA receptors.

Ranjan Dutta1, Anthony M Chomyk, Ansi Chang, Michael V Ribaudo, Sadie A Deckard, Mary K Doud, Dale D Edberg, Brian Bai, Michael Li, Sergio E Baranzini, Robert J Fox, Susan M Staugaitis, Wendy B Macklin, Bruce D Trapp.   

Abstract

OBJECTIVE: Hippocampal demyelination, a common feature of postmortem multiple sclerosis (MS) brains, reduces neuronal gene expression and is a likely contributor to the memory impairment that is found in >40% of individuals with MS. How demyelination alters neuronal gene expression is unknown.
METHODS: To explore whether loss of hippocampal myelin alters expression of neuronal microRNAs (miRNAs), we compared miRNA profiles from myelinated and demyelinated hippocampi from postmortem MS brains and performed validation studies.
RESULTS: A network-based interaction analysis depicts a correlation between increased neuronal miRNAs and decreased neuronal genes identified in our previous study. The neuronal miRNA miR-124 was increased in demyelinated MS hippocampi and targets mRNAs encoding 26 neuronal proteins that were decreased in demyelinated hippocampus, including the ionotrophic glutamate receptors AMPA2 and AMPA3. Hippocampal demyelination in mice also increased miR-124, reduced expression of AMPA receptors, and decreased memory performance in water maze tests. Remyelination of the mouse hippocampus reversed these changes.
INTERPRETATION: We establish here that myelin alters neuronal gene expression and function by modulating the levels of the neuronal miRNA miR-124. Inhibition of miR-124 in hippocampal neurons may provide a therapeutic approach to improve memory performance in MS patients.
Copyright © 2013 American Neurological Association.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23595422      PMCID: PMC3679350          DOI: 10.1002/ana.23860

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  33 in total

1.  Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity.

Authors:  Ursula Fünfschilling; Lotti M Supplie; Don Mahad; Susann Boretius; Aiman S Saab; Julia Edgar; Bastian G Brinkmann; Celia M Kassmann; Iva D Tzvetanova; Wiebke Möbius; Francisca Diaz; Dies Meijer; Ueli Suter; Bernd Hamprecht; Michael W Sereda; Carlos T Moraes; Jens Frahm; Sandra Goebbels; Klaus-Armin Nave
Journal:  Nature       Date:  2012-04-29       Impact factor: 49.962

Review 2.  The neuronal microRNA system.

Authors:  Kenneth S Kosik
Journal:  Nat Rev Neurosci       Date:  2006-12       Impact factor: 34.870

Review 3.  The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration.

Authors:  Stephen L Hauser; Jorge R Oksenberg
Journal:  Neuron       Date:  2006-10-05       Impact factor: 17.173

4.  A MicroRNA feedback circuit in midbrain dopamine neurons.

Authors:  Jongpil Kim; Keiichi Inoue; Jennifer Ishii; William B Vanti; Sergey V Voronov; Elizabeth Murchison; Gregory Hannon; Asa Abeliovich
Journal:  Science       Date:  2007-08-31       Impact factor: 47.728

Review 5.  Cognitive dysfunction in multiple sclerosis: a review of recent developments.

Authors:  Julie A Bobholz; Stephen M Rao
Journal:  Curr Opin Neurol       Date:  2003-06       Impact factor: 5.710

6.  Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression.

Authors:  Sébastien S Hébert; Katrien Horré; Laura Nicolaï; Aikaterini S Papadopoulou; Wim Mandemakers; Asli N Silahtaroglu; Sakari Kauppinen; André Delacourte; Bart De Strooper
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-23       Impact factor: 11.205

Review 7.  Natural history of multiple sclerosis.

Authors:  B G Weinshenker
Journal:  Ann Neurol       Date:  1994       Impact factor: 10.422

8.  Regional hippocampal atrophy in multiple sclerosis.

Authors:  N L Sicotte; K C Kern; B S Giesser; A Arshanapalli; A Schultz; M Montag; H Wang; S Y Bookheimer
Journal:  Brain       Date:  2008-04       Impact factor: 13.501

Review 9.  MicroRNAs (miRNAs) in neurodegenerative diseases.

Authors:  Peter T Nelson; Wang-Xia Wang; Bernard W Rajeev
Journal:  Brain Pathol       Date:  2008-01       Impact factor: 6.508

10.  Dysregulation of miRNA 181b in the temporal cortex in schizophrenia.

Authors:  Natalie J Beveridge; Paul A Tooney; Adam P Carroll; Erin Gardiner; Nikola Bowden; Rodney J Scott; Nham Tran; Irina Dedova; Murray J Cairns
Journal:  Hum Mol Genet       Date:  2008-01-09       Impact factor: 6.150

View more
  64 in total

Review 1.  MicroRNAs in Schizophrenia: Implications for Synaptic Plasticity and Dopamine-Glutamate Interaction at the Postsynaptic Density. New Avenues for Antipsychotic Treatment Under a Theranostic Perspective.

Authors:  Andrea de Bartolomeis; Felice Iasevoli; Carmine Tomasetti; Elisabetta F Buonaguro
Journal:  Mol Neurobiol       Date:  2014-11-14       Impact factor: 5.590

Review 2.  Gene expression changes underlying cortical pathology: clues to understanding neurological disability in multiple sclerosis.

Authors:  Ranjan Dutta
Journal:  Mult Scler       Date:  2013-09       Impact factor: 6.312

Review 3.  MicroRNAs in neuronal communication.

Authors:  Guilherme Shigueto Vilar Higa; Erica de Sousa; Lais Takata Walter; Erika Reime Kinjo; Rodrigo Ribeiro Resende; Alexandre Hiroaki Kihara
Journal:  Mol Neurobiol       Date:  2014-01-03       Impact factor: 5.590

4.  Decrease in levels of the evolutionarily conserved microRNA miR-124 affects oligodendrocyte numbers in Zebrafish, Danio rerio.

Authors:  Jacqueline K Morris; Anthony Chomyk; Ping Song; Nate Parker; Sadie Deckard; Bruce D Trapp; Sanjay W Pimplikar; Ranjan Dutta
Journal:  Invert Neurosci       Date:  2015-07-10

5.  Decreased number and increased volume with mitochondrial enlargement of cerebellar synaptic terminals in a mouse model of chronic demyelination.

Authors:  Huy Bang Nguyen; Yang Sui; Truc Quynh Thai; Kazuhiro Ikenaka; Toshiyuki Oda; Nobuhiko Ohno
Journal:  Med Mol Morphol       Date:  2018-05-23       Impact factor: 2.309

6.  The Anti-Aging Protein Klotho Enhances Remyelination Following Cuprizone-Induced Demyelination.

Authors:  Ella Zeldich; Ci-Di Chen; Robin Avila; Satish Medicetty; Carmela R Abraham
Journal:  J Mol Neurosci       Date:  2015-06-12       Impact factor: 3.444

Review 7.  Proteomic Approaches to Decipher Mechanisms Underlying Pathogenesis in Multiple Sclerosis Patients.

Authors:  Vaibhav Singh; Ajai Tripathi; Ranjan Dutta
Journal:  Proteomics       Date:  2019-06-21       Impact factor: 3.984

Review 8.  Epigenetic mechanisms of neurodegenerative diseases and acute brain injury.

Authors:  Mario J Bertogliat; Kahlilia C Morris-Blanco; Raghu Vemuganti
Journal:  Neurochem Int       Date:  2019-12-12       Impact factor: 3.921

9.  Glatiramer acetate guards against rapid memory decline during relapsing-remitting experimental autoimmune encephalomyelitis.

Authors:  Patrizia LoPresti
Journal:  Neurochem Res       Date:  2014-12-07       Impact factor: 3.996

10.  In vivo evidence of hippocampal dentate gyrus expansion in multiple sclerosis.

Authors:  Maria A Rocca; Giulia Longoni; Elisabetta Pagani; Giacomo Boffa; Bruno Colombo; Mariaemma Rodegher; Gianvito Martino; Andrea Falini; Giancarlo Comi; Massimo Filippi
Journal:  Hum Brain Mapp       Date:  2015-08-19       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.